BAL Lazio


HTA – Bibliografia 1999-1977

Pubblicato lunedì 5 Maggio 2014

I volumi e gli articoli citati sono in ordine cronologico, in modo da mettere in evidenza quelli più recenti, in cima all’elenco.

Battista RN, Hodge MJ. The evolving paradigm of health technology assessment: reflections for the millennium. CMAJ 1999; 160: 1464-7.

Jonsson E, Banta D. Management of health technologies: an international view. BMJ 1999; 319: 1293.

Rosen R, Gabbey J. Linking health technology assessment to practice. BMJ 1999; 319: 1-3.

Bero LA, Grilli R, Grimshaw JM, et al. Closing the gap between research and practice: An overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998; 317: 465-8.

Goodman CS. Technology assessment: A tool for technology management and improved patient outcomes. USA: The Lewin Group, 1998.

Heitman E. Ethical issues in technology assessment. Conceptual categories and procedural considerations. Int J Technol Assess Health Care 1998; 14 (3): 544-66.

Sheldon TA, Guyatt GH, Haines A. Getting research findings in to practice – When to act on evidence. BMJ 1998; 317: 149-52.

Chancellor J, Coyle D, Drummond MF. Constructing health state preference values from descriptive quality of life data: mission impossible? Qual Life Res 1997; 6 (2): 159-68.

Favaretti C, Liberati A, De Pieri P, et al. Dalla medicina all’assistenza sanitaria basata su prove di efficacia: la sfida dell’aziendalizzazione del servizio sanitario nazionale. In: Liberati A, ed. La medicina delle prove di efficacia. Roma: Il Pensiero Scientifico Editore, 1997; 137-61.

Jacob R, Mc Gregor M. Assessing the impact of health technology assessment. Int J Technol Assess Health Care 1997; 13: 68-80.

Birch S, Gafni A. Cost effectiveness and cost utility analysis: methods for the non – economic evaluation of health care programmers and how we can do better. In: Geilser E, Heller O, eds. Managing technology in health care. Norwell, MA: Klewer Academic Publishers, 1996; 51-68.

Epstein RE, Sherwood LM. From outcomes research to disease management: A guide for the perplexed. Ann Intern Med 1996; 124: 832-7.

Raiseman. Management technologies for managing the health care sector technologies. In: Geisler E, Heller O, eds. Managing technology in health care. Boston: Kluwer Academic Publisher, 1996.

Sculpher MJ, Drummond MF, Buxton MJ. The iterative use of economic evaluation as part of the process of health assessment. J Health Serv Res Policy 1996; 1 (4).

Van Roijen L, Essink-Bot ML, Koopmanschap MA, et al. Labor and health status in economic evaluation of health care. Int J Technol Assess Health Care 1996; 12 (3): 405-15.

Battista RN, Vineis P, Hodge MJ. Medicine, practice and guidelines: The uneasy juncture of science and art. J Clin Epidemiol 1995; 48: 875-80.

ten Have H. Medical Technology assessment and ethics. Ambivalent relations. Hastings Cent Rep 1995; 25 (5): 13-9.

Battista RN. Scienze della salute, decisioni politiche e valutazione delle tecnologie sanitarie: sta espandendosi il ruolo degli epidemiologi? Epid Rev 1994 (18): 15-21.

Briggs AH, Schulpher MJ, Buxton MJ. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 1994; 3: 95-104.

Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life. Ann Intern Med 1993; 118: 622-9.

Johannesson M, Jönsson B. Economic evaluation in health care: is there a role for cost-benefits? Health Policy 1991; 17: 1-23.

Battista RN, Contandriopoulos AP, Champagne F. An integrative framework for health-related research. J Clin Epidemiol 1989; 42 (12): 1155-60.

Deber RB. Metodologie di valutazione della tecnologia e il loro impatto sul “Decision Making”. Proceedings of the Symposium on Health Care Technology Assessment. Quebec City, May 25-26, 1989.

Donabedian A. The assessment of technology and quality: a comparative study of certainties and ambiguities. Int J Tech Assess Health Care 1988; 4: 487-96.

Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ 1986; 5: 1-30.

Jonas H. Technik, medizin und ethik. Zur praxis des prinzips verantwortung. Frankfurt am Main: Insel verlag; 1985 (trad. it. Tecnica, medicina ed etica. Prassi del principio responsabilità. Torino: Giulio Einaudi Editore, 1997).

Drummond MF, Stoddart GL. Economic analysis and clinical trial. Control Clin Trials 1984; 5: 115-28.

Stoddart GL. Economic evaluation methods of health policy. Eval Health Prof 1982; 5 (4): 309-30.

Drummond MF. Welfare economics and cost benefit analysis in health care. Scott Polit Econ 1981; 28: 125-45.

Weinstein MC. Economic assessments of medical practices and technologies. Med Decis Making 1981; 1 (4): 309-30.

Williams AH. Welfare economics and health status measurement. In: van der Gaag J, Pearlman M, ed. Health, economics and health economics. Amsterdam: North Holland, 1981; 271-81.

Mehrez A, Gafni A. Quality adjusted life years, utility theory and health years equivalents. Med Decis Making 1989; 9: 142-9.Sackett DL. Evaluation of health services. In: Last JM. Health and preventive medicine. New York: Appleton – Century Crofts, 1980; 1800-23.

Weinstein MC, Statson WB. Foundations of cost effectiveness analysis for health and medical practices. N Eng J Med 1977; 296: 716-21.

Archiviato in ,

Lascia un commento

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Accedi agli articoli

Hartmann‐Boyce  J, McRobbie  H, Bullen  C, Begh  R, Stead  LF, Hajek  P. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 9. Art. No.: CD010216. DOI:

Miovský M et al. Attention Deficit Hyperactivity Disorder among clients diagnosed with a substance use disorder in the therapeutic communities: prevalence and psychiatric comorbidity. Eur Addict Res 2020.

Ortel TL et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 2020; 4(19): 4693-4738.

Chu JJ et al. Mifepristone and misoprostol versus misoprostol alone for the management of missed miscarriage (MifeMiso): a randomised, double-blind, placebo-controlled trial. Lancet 2020 Sep 12;396(10253):770-778.

Vodicka TA et al. Reducing antibiotic prescribing for children with respiratory tract infections in primary care: a systematic review. Br J Gen Pract 2013;63(612):e445-54.

Dominici F, et al. Air pollution, SARS-CoV-2 transmission, and COVID-19 outcomes: a state-of-the-science review of a rapidly evolving research area. medRxiv 2020. doi:

Marion M Mafham et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 2020;S0140-6736(20)31356-8.

Orkaby AR. Association of statin use with all-cause and cardiovascular mortality in US veterans 75 years and older. JAMA 2020;324(1):68-78

Lethaby AE et al. Progesterone/progestogen releasing intrauterine systems versus either placebo or any other medication for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(2):CD002126. doi: 10.1002/14651858.CD002126.

Levis B. Accuracy of the PHQ-2 alone and in combination with the PHQ-9 for screening to detect major depression: systematic review and meta-analysis. JAMA 2020;323(22):2290-2300.

Una finestra sull’open access

  • BMC Family Practice
  • BMC Medical Education
  • BMC Nursing
  • BMJ Open
  • PLOS Medicine

Reset della password

Per favore inserisci la tua email. Riceverai una nuova password via email.